MACAMI BIOTECH SL is the world's first company created to leverage microalgae biotechnology in the nutraceutical sector, developing innovative solutions to prevent chronic diseases prevalent in modern society. In an opaque supplement market saturated with mere ingredients, Macami stands out for its quality and transparency, showcasing the origin and cultivation method of its microalgae and offering complete nutraceutical formulas for specific goals, with scientifically validated ingredients. Furthermore, it collaborates with the Spanish National Research Council (CSIC) and the Spanish Center for Algal Research (CIAL) on projects aimed at generating knowledge and transforming it into products accessible to everyone. With a focus on research, efficacy, safety, and sustainability, Macami aims to integrate its nutraceuticals into the daily routine of any individual to improve the overall well-being of society.
- ACTIVITY: Nutraceutical products based on microalgae.
- LOCATION: MADRID
- CONSTITUTION DATE: 24/10/2024
- CATEGORY: Nutrition
- CONTACT: info@macambiotech.com
- WEB: www.macamibiotech.com
- NUMBER OF EMPLOYEES: 4.
- INCOME: €1-2 million.
- GENERAL DESCRIPTION: Marketing of microalgae-based nutraceutical solutions for all types of audiences in a B2C model.
- BUSINESS LINES: Nutraceuticals (cosmoceuticals will arrive in 2026).
- INFRASTRUCTURE: Lean business model.
TECHNOLOGICAL SUPPLY/DEMAND:
- Collaborations for the study of the bioactivity of different species of microalgae in human health.
- Collaborations with European microalgae producers.
English 
Spanish